Purchase Order 75N91024P00545
Award Date 7/2/24
Potential Completion Date 7/1/26
Potential Value $2M
Federal Agency
Ultimate Awardee
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health, to Becton, Dickinson and Company (BD) for a flow cytometry maintenance agreement. The contract has a ceiling value of $353,344.70 and a period of performance through November 29, 2024. BD is a global medical technology company that provides specialized equipment, reagents, and services for biomedical research and clinical applications, including...
- This is a $18,351.36 firm fixed price delivery order contract awarded by the NIH Clinical Center to Becton, Dickinson and Company (BD) for specialized flow cytometry equipment, cell imaging technologies, and genomics solutions. The contract has an ultimate completion date of August 29, 2026. BD is a large, established medical technology manufacturer that has a long-standing relationship with government research and healthcare institutions, receiving numerous contracts from agencies such as...
- This federal contract award to Becton, Dickinson and Company (BD), through its BD Biosciences division, is for the maintenance of flow cytometers for the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The fixed-price contract, valued at $199,485.72, has a period of performance through October 11, 2022. BD is a global medical technology company that provides a wide range of products and services to U.S. government agencies,...
- This is a firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI) to Becton, Dickinson and Company (BD) for $161,406.02. The contract is for BD Biosciences, a division of BD, to provide specialized equipment, reagents, and services to support biomedical research and clinical applications through flow cytometry, cell imaging, and genomics technologies. BD is a global medical technology company that has extensive experience providing a wide range of goods and...
- This is a firm-fixed-price delivery order awarded to Becton, Dickinson and Company (BD) by the National Cancer Institute (NCI), a component of the National Institutes of Health. The $33,250.30 contract is for flow cytometric analysis of benign and malignant tumors. BD, a global medical technology company, provides instruments, reagents, and services that support biomedical research and clinical applications through flow cytometry, cell imaging, and genomics technologies. The contract does not...
- This is a federal contract award to Becton, Dickinson and Company (BD), a global medical technology company, by the National Institutes of Health (NIH) Clinical Center. The $66,373.80 firm fixed-price purchase order is for the delivery of flow cytometry instruments, maintenance services, and related consumables to support biomedical research and clinical applications across various NIH components, including the National Institute of Allergy and Infectious Diseases (NIAID), National Cancer...
- This federal contract award is a firm-fixed-price purchase order for $44,161.20 from the National Institutes of Health (NIH) Clinical Center to Becton, Dickinson and Company (BD) for preventative maintenance services on several pieces of BD flow cytometry equipment. The contract covers maintenance on a BD FACSLyric flow cytometer, a BD Universal Loader, and a BD FACS Duet through August 2026. This contract is not a set-aside award. BD is a large, established manufacturer of medical devices,...
- This is a $17,118.00 firm fixed price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) to provide a service contract to maintain a flow cytometer. The contract period of performance is June 2, 2025 through June 1, 2026. No set-aside designation was used for this award. BD is a global medical technology company that develops, manufactures, and sells medical devices,...
- This is a firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for maintenance and support services for a BD LSR Fortessa flow cytometry instrument and associated instrumentation. The contract has a base period from August 1, 2021 to July 31, 2024, with a ceiling value of $73,900.44. The contract was awarded competitively without a set-aside designation, indicating...
- This firm-fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health within the Department of Health and Human Services, to Becton, Dickinson and Company (BD) for the provision of laboratory equipment from the BD Biosciences division. The contract has a potential value of $237,617.52 and a period of performance through March 31, 2024. No set-aside designation was used. BD is a global medical technology...